Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Antisense oligonucleotide directed removal of proteolytic cleavage sites, the HCHWA-D mutation, and trinucleotide repeat expansions

Antisense oligonucleotide directed removal of proteolytic cleavage sites, the HCHWA-D mutation, and trinucleotide repeat expansions

US Patent 10590421 · Granted Mar 17, 2020

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Methods and means for efficient skipping of exon 45 in Duchenne muscular dystrop2022
Means and methods for counteracting muscle disorders2021
Means and methods for counteracting muscle disorders2021
Antisense oligonucleotide directed removal of proteolytic cleavage sites from pr2019
Antisense oligonucleotide directed removal of proteolytic cleavage sites from pr2019
Antisense oligonucleotide directed removal of proteolytic cleavage sites from pr2019
Antisense oligonucleotide directed removal of proteolytic cleavage sites from pr2019
Antisense oligonucleotide directed removal of proteolytic cleavage sites from pr2019
Method for efficient exon (44) skipping in duchenne muscular dystrophy and assoc2019
Method for efficient exon (44) skipping in duchenne muscular dystrophy and assoc2019
Modulation of exon recognition in pre-mRNA by interfering with the secondary RNA2018
Modulation of exon recognition in pre-mRNA by interfering with the secondary RNA2018